International stock news

Rss Today on Proactive AU

2015-07-08

Admedus’ CardioCel has long term potential for congenital heart disease

 
That 11 patients are now past 5 years post implantation with no sign of calcification is strong evidence of CardioCel’s long term patient outcomes for repairing congenital heart defects. The company is expanding its use into the adult cardiac and the peripheral vascular markets.
FULL ARTICLE

 

Rss Today on Proactive UK

2015-07-08

Enertopia adds Amazon.ca to list of online V-Love retailers

 
Amazon.ca’s main distribution facility in Mississauga, Ontario, has received the first shipment of V-Love and is ready to deliver it to consumers throughout Canada after they order it online by going to amazon.ca, entering vlove in the search field and completing a purchase order.
FULL ARTICLE

 

Rss Today on Proactive US

2015-07-08

VolitionRX seeks to revolutionise cancer diagnosis Share

 
New York-listed VolitionRx aims to revolutionise cancer screening, and its chief executive Cameron Reynolds explains to Proactive Investors the basics behind the company’s technology, which works on a “very, very small amount of blood”, and is less invasive and more cost-effective than many competing diagnostic processes. Results from trials of the technology have been very encouraging, and the European CE mark for the first test – on colorectal cancer – could be secured within a year with approval from the US’s Food and Drug Administration set to follow the following year. With 93mln people undergoing these diagnostic tests every two or three years, the market for the company’s products is enormous.
FULL ARTICLE